Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Adaptive Biotechnologies Corp shares valued at $121,079 were sold by Taylor Stacy L on Aug 22 ’24. At $4.50 per share, Taylor Stacy L sold 26,922 shares. The insider’s holdings dropped to 139,365 shares worth approximately $0.72 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, STACY L TAYLOR purchased 26,922 shares, netting a total of over 121,079 in proceeds.
Before that, PISKEL KYLE had sold 7,727 shares from its account. In a trade valued at $26,504, the Principal Accounting Officer traded Adaptive Biotechnologies Corp shares for $3.43 each. Upon closing the transaction, the insider’s holdings decreased to 7,727 shares, worth approximately $0.63 million.
Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in early January. As of December 21, 2022, Piper Sandler has increased its “Neutral” rating to a “an Overweight” for ADPT. Earlier on August 25, 2022, Credit Suisse initiated its rating. Their recommendation was “an Underperform” for ADPT stock.
Analyzing ADPT Stock Performance
During the last five days, there has been a surge of approximately 28.50%. Over the course of the year, Adaptive Biotechnologies Corp shares have jumped approximately 4.90%. Shares of the company reached a 52-week high of $5.53 on 09/26/24 and a 52-week low of $2.28 on 04/19/24. A 50-day SMA is recorded $4.54, while a 200-day SMA reached $3.87. Nevertheless, trading volume fell to 0.98 million shares from 1.19 million shares the previous day.
Support And Resistance Levels for Adaptive Biotechnologies Corp (ADPT)
According to the 24-hour chart, there is a support level at 4.98, which, if violated, would cause prices to drop to 4.82. In the upper region, resistance lies at 5.25. The next price resistance is at 5.36. RSI (Relative Strength Index) is 61.68 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.42, which suggests the price will decrease in the coming days. Percent R is at 25.18%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
